Vascular and Metabolic Implications of Novel Targeted Cancer Therapies

This publication has 118 references indexed in Scilit:

• Molecular mechanisms and clinical applications of angiogenesis
  Nature, 2011
• Hypertension as a Biomarker of Efficacy in Patients With Metastatic Renal Cell Carcinoma Treated With Sunitinib
  JNCI: Journal of the National Cancer Institute, 2011
• Multicenter Independent Assessment of Outcomes in Chronic Myeloid Leukemia Patients Treated With Imatinib
  JNCI: Journal of the National Cancer Institute, 2011
• Bleeding events in bevacizumab-treated cancer patients who received full-dose anticoagulation and remained on study
  British Journal of Cancer, 2011
• Initial Assessment, Surveillance, and Management of Blood Pressure in Patients Receiving Vascular Endothelial Growth Factor Signaling Pathway Inhibitors
  JNCI: Journal of the National Cancer Institute, 2010
• Tyrosine kinase inhibitors reverse type 1 diabetes in nonobese diabetic mice
  Proceedings of the National Academy of Sciences, 2008
• Efficacy of everolimus in advanced renal cell carcinoma: a double-blind, randomised, placebo-controlled phase III trial
  The Lancet, 2008
• VEGF Inhibition and Renal Thrombotic Microangiopathy
  New England Journal of Medicine, 2008
• Critical nodes in signalling pathways: insights into insulin action
  Nature Reviews Molecular Cell Biology, 2006
• Tumor Angiogenesis: Therapeutic Implications
  New England Journal of Medicine, 1971